SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001372514-23-000125
Filing Date
2023-09-01
Accepted
2023-09-01 07:00:16
Documents
13
Period of Report
2023-08-31
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K kprx-20230831.htm   iXBRL 8-K 28129
2 EX-99.1 ex991-pressreleasespecialp.htm EX-99.1 10631
  Complete submission text file 0001372514-23-000125.txt   172603

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT kprx-20230831.xsd EX-101.SCH 1919
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT kprx-20230831_lab.xml EX-101.LAB 24851
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT kprx-20230831_pre.xml EX-101.PRE 13058
7 EXTRACTED XBRL INSTANCE DOCUMENT kprx-20230831_htm.xml XML 2813
Mailing Address 332 ENCINITAS BOULEVARD SUITE 102 ENCINITAS CA 92024
Business Address 332 ENCINITAS BOULEVARD SUITE 102 ENCINITAS CA 92024 781-788-8869
KIORA PHARMACEUTICALS INC (Filer) CIK: 0001372514 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36672 | Film No.: 231230571
SIC: 2834 Pharmaceutical Preparations